Orrick Herrington & Sutcliffe LLP advised Leaps by Bayer on the deal. Leaps by Bayer, the impact investment arm of Bayer AG, has entered into a...
Bayer’s Join Investment With Temasek In Unfold
Palladin Consumer Retail Partners’ Investment In Decowraps
Proskauer Rose represented Decowraps and its Founder and CEO, Steven Tchira, while Morgan, Lewis & Bockius acted as legal counsel to Palladin. Palladin Consumer Retail Partners,...
PEP Fund VI’s $1.79 Billion Fundraising
Ropes & Gray represented Pacific Equity Partners (PEP) in the transaction. Pacific Equity Partners (PEP) closed its sixth core fund, PEP Fund VI, with AUD$2.5 billion...
iRhythm Technologies, Inc.’s $191 Million Follow-On Offering
Wilson Sonsini Goodrich & Rosati advised iRhythm Technologies, Inc on the deal. iRhythm Technologies, Inc., a leading digital health care solutions company focused on the advancement...
Barings BDC’s Merger with MVC Capital
J.P. Morgan served as sole financial advisor, Dechert LLP and B2RLaw served as legal counsel to Barings BDC; JMP Securities served as financial advisor and Kramer...
Johnson V. Costco Wholesale Corporation
Wilson Sonsini Goodrich & Rosati advised Costco Wholesale Corporation on the deal. On August 19, 2020, the U.S. District Court for the Western District of Washington...
Royal Caribbean Group’s $700 Million Term Loan Facility
Skadden, Arps, Slate, Meagher & Flom LLP advised Royal Caribbean Group on the deal, while Perella Weinberg Partners LP served as financial advisor. Royal Caribbean Group...
Kinder Morgan, Inc.’s $1.25 Billion Debt Offering
Hunton Andrews Kurth advised the underwriters on the deal. Bracewell LLP advised Kinder Morgan, Inc. on the deal. Kinder Morgan Inc., one of the largest energy...
Tango Therapeutics’ $145 Million Collaboration Agreement With Gilead
Wilson Sonsini Goodrich & Rosati advised Tango Therapeutics on the deal. Gilead Sciences, Inc. and Tango Therapeutics announced an expanded strategic collaboration focused on the discovery,...
Ligand’s $516 million Acquisition Of Pfenex
Wilson Sonsini Goodrich & Rosati advised Pfenex Inc. on the deal. Ligand Pharmaceuticals and Pfenex Inc. announced the signing of a definitive agreement for Ligand to...
VelosBio’s $137 Million Series B Investment
Choate represented Surveyor Capital in the transaction. VelosBio Inc., a clinical-stage biopharmaceutical company committed to developing novel, first-in-class cancer therapies targeting receptor tyrosine kinase-like orphan receptor...
Mission Bio, Inc.’s $70 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised Mission Bio, Inc. on the deal. Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced a...